TORONTO, April 20, 2026 (GLOBE NEWSWIRE)-- Conavi Medical Corp., a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common ...
NEW ORLEANS — Intravascular ultrasound (IVUS) is already guideline recommended for complex percutaneous coronary interventions (PCIs), so when IVUS failed to outperform angiography in two new ...
In patients with acute coronary syndrome (ACS), intravascular ultrasound (IVUS)-guided implantation of a drug-eluting stent improved outcomes compared with angiography guidance alone. "Our study ...
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (CNVI:CA) (“Conavi” or the “Company”), a leader in hybrid intravascular imaging technologies, today highlighted the publication of new ...
Using intravascular imaging to guide stent implantation during percutaneous coronary intervention (PCI) in heart disease patients significantly improves survival and reduces adverse cardiovascular ...
- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion ...
- Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp., a commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results